Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

US health officials announced on Friday that they were awarding US$590 million to Moderna to develop mRNA vaccines against ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

Moderna stock (MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US ...

Plexi Images / GHI / UCG / Universal Images Group via Getty Images Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S ...

Moderna stock gained 14% ... the Centers for Disease Control and Prevention reported the first death from bird flu on Monday, announcing an elderly patient with underlying medical conditions ...

Ryan/The Boston Globe via Getty Images Vaccine makers' stocks surged on Tuesday after the US reported its first bird flu death. Moderna, Novavax, and CureVac saw double-digit gains, while Pfizer ...